Clinical Trial: CXCL9 and EASIX for Prediction of Acute Graft Versus Host Disease
Study Status: Completed
Recruit Status: RECRUITING
Condition: GVHD,Acute
Study Type: OBSERVATIONAL
Official Title: CXC-chemokine Ligand 9 (CXCL9) and Endothelial Activation and Stress Index (EASIX) for Prediction of Acute Graft Versus Host Disease
Brief Summary:
The prediction of severe acute GVHD before it occurs is of high importance for ensuing clinical decisions and overall success of allogeneic SCT.The key immunologic signatures associated with clinical outcomes after different graft versus host disease prophylaxis methods or peripheral blood stem cell transplant are largely unknown.
Read more